Skip to main content
Log in

Patients treated with immunosuppressive steroids are less aware of sick day rules Than those on endocrine replacement therapy and may be at greater risk of adrenal crisis

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Patients taking corticosteroids for immune suppression are vulnerable to adrenal crisis during acute illness or if steroids are stopped abruptly. Although patients treated for adrenal failure in endocrine units are routinely provided with sick day guidelines, we wished to ascertain whether patients on immunosuppressive steroids are appropriately advised.

Aim

This study sets out to compare patient awareness of steroid sick day rules in endocrine and non-endocrine patients.

Design

A short case history is presented to illustrate the clinical impact of adrenal crisis in a patient on immune suppression. Subsequently, we present the results of a 9-point questionnaire, devised to determine knowledge of steroid sick day rules, in two patient cohorts. In group 1, patients on immunosuppressive steroids were recruited from non-endocrine clinics to complete the questionnaire. In group 2, patients on replacement steroids were recruited from endocrine clinics.

Results

Endocrine patients exhibited better steroid use awareness; they were more likely to double their steroid dose when ill (89 v/s 23%), to obtain parenteral steroid during vomiting (83 v/s 27%), or during surgery (87 v/s 30%), and were aware of the need to carry a MedicAlert bracelet or a steroid-aware card (82 v/s 21%), (p < 0.001 for all comparisons).

Conclusion

Endocrine patients exhibited a significantly greater knowledge of sick day rules. The data does highlight the lack of patient awareness of the precautions for steroid use in patients on immunosuppressive steroid therapy for non-endocrine conditions, and the case presentation illustrates the potential hazards of this lack of awareness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Smith MD, Cheah SP, Taylor K, Ahern MJ (2001) Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. J Rheumatol 28:566–570

    CAS  PubMed  Google Scholar 

  2. Hahner S, Loeffler M, Bleicken B et al (2010) Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 162:597–602. doi:10.1530/EJE-09-0884

    Article  CAS  PubMed  Google Scholar 

  3. Peacey SR, Pope RM, Naik KS et al (1993) Corticosteroid therapy and intercurrent illness: the need for continuing patient education. Postgrad Med J 69:282–284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Burman P, Mattsson AF, Johannsson G et al (2013) Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 98:1466–1475. doi:10.1210/jc.2012-4059

    Article  CAS  PubMed  Google Scholar 

  5. Bensing S, Brandt L, Tabaroj F et al (2008) Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol 69:697–704. doi:10.1111/j.1365-2265.2008.03340.x

    Article  Google Scholar 

  6. Woods CP, Argese N, Chapman M et al (2015) Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol 173:633–642. doi:10.1530/EJE-15-0608

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G (2006) Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853. doi:10.1210/jc.2006-0076

    Article  CAS  PubMed  Google Scholar 

  8. Hahner S, Spinnler C, Fassnacht M et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100:407–416. doi:10.1210/jc.2014-3191

    Article  CAS  PubMed  Google Scholar 

  9. van Staa TP, Leufkens HG, Abenhaim L et al (2000) Use of oral corticosteroids in the United Kingdom. QJM 93:105–111

    Article  PubMed  Google Scholar 

  10. Henzen C, Suter A, Lerch E et al (2000) Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet (London, England) 355:542–545. doi:10.1016/S0140-6736(99)06290-X

    Article  CAS  Google Scholar 

  11. Sacre K, Dehoux M, Chauveheid MP et al (2013) Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study. J Clin Endocrinol Metab 98:3199–3205. doi:10.1210/jc.2013-1394

    Article  CAS  PubMed  Google Scholar 

  12. Cuesta M, Garrahy A, Slattery D et al (2016) The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective single-centre study. Clin Endocrinol. doi:10.1111/cen.13128

    Google Scholar 

  13. Repping-Wuts HJWJ, Stikkelbroeck NMML, Noordzij A et al (2013) A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol 169:17–22. doi:10.1530/EJE-12-1094

    Article  CAS  PubMed  Google Scholar 

  14. Flemming TG, Kristensen LO (1999) Quality of self-care in patients on replacement therapy with hydrocortisone. J Intern Med 246:497–501

    Article  CAS  PubMed  Google Scholar 

  15. (1998) Committee on Safety of Medicines/Medicines Control Agency. Focus on corticosteroids. Curr Probl Pharmacovigil 24:5–10

  16. Downie WW, Leatham PA, Rhind VM, Wright V (1977) Steroid cards: patient compliance. Br Med J 1:428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Johnson AJ (1979) Use of steroid cards by patients with respiratory disease. Thorax 34:274–275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Harbeck B, Brede S, Witt C et al (2015) Glucocorticoid replacement therapy in adrenal insufficiency—a challenge to physicians? Endocr J 62:463–468. doi:10.1507/endocrj.EJ14-0612

    Article  CAS  PubMed  Google Scholar 

  19. Wass JAH, Arlt W (2012) How to avoid precipitating an acute adrenal crisis. BMJ 345:e6333

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the consultants from Rheumatology, Respiratory Medicine, Nephrology and Gastroenterology in our hospital, for their support in contacting study participants at their respective out-patients clinic.

Author information

Authors and Affiliations

Authors

Contributions

All authors had access to the data and a role in writing the manuscript.

Corresponding author

Correspondence to C. J. Thompson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

Nothing to declare.

Appendix

Appendix

Table 3 Steroid questionnaire to review awareness of precautions

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salehmohamed, M.R., Griffin, M., Branigan, T. et al. Patients treated with immunosuppressive steroids are less aware of sick day rules Than those on endocrine replacement therapy and may be at greater risk of adrenal crisis. Ir J Med Sci 187, 69–74 (2018). https://doi.org/10.1007/s11845-017-1607-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-017-1607-y

Keywords

Navigation